0A7L.LSE iRhythm Technologies, Inc.
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is 0A7L.LSE undervalued?
Graham numberThe Graham number of iRhythm Technologies, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
iRhythm Technologies, Inc. fundamental analysis
No fundamental analysis for iRhythm Technologies, Inc. yet.
iRhythm Technologies, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About iRhythm Technologies, Inc.
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electro…
Full company profileFinancial statements of iRhythm Technologies, Inc. are not available yet.
iRhythm Technologies, Inc. dividends
iRhythm Technologies, Inc. has not paid dividends in the last 4 fiscal years.
Who owns iRhythm Technologies, Inc.
- Insiders 1.17%
- Institutions 98.83%
- Public & others 0.00%
- Free float 30.3M
iRhythm Technologies, Inc. company profile
- Company name
- iRhythm Technologies, Inc.
- Ticker
- 0A7L.LSE
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 2,400
- Fiscal year end
- December
- Address
- 699 8th Street, San Francisco, CA, United States, 94103
- Phone
- 415 632 5700
- Website
- irhythmtech.com
About iRhythm Technologies, Inc.
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
iRhythm Technologies, Inc. management
10- Mr. Quentin S. BlackfordPresident, CEO & Director · born 1979
- Mr. Daniel G. WilsonCFO & Principal Financial Officer · born 1982
- Dr. Minang P. Turakhia M.D., M.S.Chief Medical & Scientific Officer and Executive VP of Advanced Technologies · born 1974
- Mr. Patrick Michael Murphy J.D.Chief Business & Legal Officer · born 1979
- Mr. Chad M. PattersonChief Commercial and Product Officer · born 1982
- Mr. Mervin SmithExecutive Vice President of Business Operations · born 1975
- Mr. Marc RosenbaumSenior VP of Finance & Chief Accounting Officer · born 1973
- Mr. Brian LawrenceExecutive VP & CTO · born 1970
- Ms. Lisa PecoraSenior Vice President of Finance & Investor Relations
- Mr. Sean Clinton FreemanExecutive Vice President of Strategy & Corporate Development · born 1976